Press Releases
Welcome to our Press Releases page, where you’ll find the latest updates and announcements from Ventripoint Diagnostics Ltd. This section is dedicated to keeping you informed about our groundbreaking developments, strategic partnerships, and significant milestones. Stay connected with us as we continue to advance the field of cardiac diagnostics, ensuring you’re always in the know about our progress and achievements.
2024
July 12, 2024
Ventripoint Announces Expansion of Collaboration with ASCEND Cardiovascular, a Leading Provider of Cardiovascular IT Solutions Across North America
July 2, 2024
Ventripoint Announces Closing of Second Tranche of Non-Brokered Convertible Debenture Private Placement and the Extension of the Offering
June 27, 2024
Ventripoint Announces Extension of Non-Brokered Convertible Debenture Private Placement
June 24, 2024
Ventripoint To Present Its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect
June 13, 2024
Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management
June 10, 2024
Ventripoint Diagnostics Announces Shareholder Update and Teleconference
May 30, 2024
Ventripoint Commits to Fight Against Forced Labour and Child Labour in Supply Chains
May 14, 2024
Ventripoint Applies for Extension of Non-Brokered Convertible Debenture Private Placement
May 13, 2024
Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Private Placement
May 6, 2024
Ventripoint’s Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration
May 1, 2024
Duke University Health Center — One of America’s Top Heart-care Institutions and Innovators — Purchases Ventripoint’s AI Heart-scan Technology
March 04, 2024
Enhanced Design Breakthrough Makes Ventripoint’s VMS+ Even Simpler to Use
February 13, 2024
Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales
February 13, 2024
Ventripoint Announces Changes to The Board of Directors
February 20, 2024
Ventripoint Successfully Showcases A.I.- Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences
January 24, 2024
Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint’s Clinical Advisory Board
2023
December 12, 2023
ASCEND Cardiovascular to Market and Distribute Ventripoint’s AI-Powered Heart-Scanning Technology to North American Hospitals and Clinics
December 5, 2023
Ollie Hinkle Heart Foundation Will Introduce Ventripoint’s AI-Heart-Imaging Diagnostic Technology to America’s Hospitals
November 30, 2023
Ventripoint Diagnostics Reports Third Quarter 2023 Financial Results
November 24, 2023
Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar
November 9, 2023
Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference
November 3, 2023
Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting
November 1, 2023
Ventripoint to Hold Annual General Meeting of Shareholders
October 12, 2023
Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference
September 28, 2023
Ventripoint’s AI Heart Technology Takes Centre Stage In ITN Business “The Hidden Heart” Programme
September 15, 2023
Ventripoint to Sponsor DGPK Echo Advanced Workshop
September 13, 2023
Ventripoint to Sponsor 51st Annual Nordic Paediatric Cardiology Meeting
September 8, 2023
Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium
August 30, 2023
Ventripoint Diagnostics Reports Second Quarter 2023 Financial Results
August 25, 2023
Ventripoint Announces Date and Timing for Release of Q2 2023 Financial Results and Webinar
August 22, 2023
Ventripoint Welcomes Evelina London Children’s Hospital as Newest VMS+ User
August 18, 2023
Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular
August 10, 2023
Ventripoint Announces Collaboration with Ascend Cardiovascular
August 2, 2023
Ventripoint Diagnostics to Attend 8th World Congress of Paediatric Cardiology and Cardiac Surgery
July 18, 2023
Ventripoint's VMS+ Purchased by University of Freiburg Medical Center
July 11, 2023
Ventripoint to Sponsor Advanced Imaging 2023 in London England
July 5, 2023
Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany
May 30, 2023
Ventripoint Receives European Union Medical Device Regulation Certification
May 29, 2023
Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results
May 17, 2023
Ventripoint Issues Option Grants and Reports Exercise of Options
May 2, 2023
Ventripoint Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results
April 25, 2023
Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
March 16, 2023
Ventripoint Diagnostics Provides a Corporate Update